Office of Biomedical Professors;
Samsung Medical Center;
Sungkyunkwan University School of Medicine;
Seoul;
Korea;
Department of Gynecology;
Asan Medical Center;
University of Ulsan College of Medicine;
Seoul;
Korea;
Department of Oncology;
Asan Medical Center;
University of Ulsan College of Medicine;
Seoul;
Korean;
Department of Urology;
Asan Medical Center;
University of Ulsan College of Medicine;
Seoul;
Korean;
Department of Laboratory Medicine;
Asan Medical Center;
University of Ulsan College of Medicine;
Seoul;
Korea;
FCB-Pharmicell Co;
Ltd;
Seoul;
Korea;
疫苗接种; IL-2; 治疗性; 卵巢癌; 患者; DC; 特异性免疫; 相位;